Strategic guidance for technical founders in biotech
Hey {{first_name|default:there}}, it’s Vadim 👋
I'm incredibly excited to kick off something I've been working on for a while: the 6-Week Investor Sourcing Intensive.
Over the next month and a half, we're going to build your dream investor list together - systematically, strategically, and ready to activate in Q1.
Why I'm doing this:
I've watched too many brilliant founders waste months (and in some cases, years) pitching zombie funds, investors who don't do biotech, and people who will never write a check.
Finding the right investors is exponentially harder in biotech than any other industry. Your market is fragmented. Your timelines are longer. Your science is complex. The "Top 100 VC" lists floating around LinkedIn? Useless for pre-seed biotech founders.
Today, I want to change that. This intensive is designed to take you from scattered and reactive to an intentional and strategic fundraise.
Why now:
Q1 is when you want to be fundraise-ready. JPM happens in January. Investors are back from holidays with fresh budgets and renewed focus. If you want to hit the ground running in Q1 2026, December is when you build your list - not when you start pitching.
Here's what we're covering:
🧭 Week 1 (Today): The SIFT System - your complete investor intelligence framework
🧭 Week 2: Angels & Angel Groups - finding biotech-savvy angels who write $25K-$500K checks
🧭 Week 3: Family Offices - demystifying the most opaque capital source in biotech
🧭 Week 4: Micro-VCs - the $2M-50M funds perfect for pre-seed (and how to find them)
🧭 Week 5: Established VCs - understanding fund hierarchy and when to target mid-size vs mega-funds
🧭 Week 6: Putting it all together - databases, AI tools, qualification process, your final 200-300 targets
By December 31st, you'll have a qualified, tiered, strategic investor list ready to go. No more guessing. No more wasted meetings. Just a clear roadmap.
Let's get started.